NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $1.46 million. The enterprise value is $3.51 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 4.85 million shares outstanding.
| Current Share Class | 4.84M |
| Shares Outstanding | 4.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 0.35% |
| Float | 4.84M |
Valuation Ratios
The trailing PE ratio is 0.26.
| PE Ratio | 0.26 |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| Forward PS | n/a |
| PB Ratio | 0.07 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 5.87 |
| EV / Sales | 0.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.54.
| Current Ratio | 2.21 |
| Quick Ratio | 1.97 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.22 |
Financial Efficiency
Return on equity (ROE) is 307.05% and return on invested capital (ROIC) is -58.21%.
| Return on Equity (ROE) | 307.05% |
| Return on Assets (ROA) | -31.32% |
| Return on Invested Capital (ROIC) | -58.21% |
| Return on Capital Employed (ROCE) | -32.85% |
| Revenue Per Employee | $62,712 |
| Profits Per Employee | $7,854 |
| Employee Count | 76 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 32.82 |
Taxes
| Income Tax | -486,706 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.95% in the last 52 weeks. The beta is -0.13, so NewGenIvf Group's price volatility has been lower than the market average.
| Beta (5Y) | -0.13 |
| 52-Week Price Change | -99.95% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 19.72 |
| Relative Strength Index (RSI) | 17.44 |
| Average Volume (20 Days) | 2,504,065 |
Short Selling Information
The latest short interest is 86,200, so 1.78% of the outstanding shares have been sold short.
| Short Interest | 86,200 |
| Short Previous Month | 320,196 |
| Short % of Shares Out | 1.78% |
| Short % of Float | 1.78% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $4.77 million and earned $596,875 in profits. Earnings per share was $1.17.
| Revenue | 4.77M |
| Gross Profit | 1.50M |
| Operating Income | -4.11M |
| Pretax Income | 125,006 |
| Net Income | 596,875 |
| EBITDA | -4.10M |
| EBIT | -4.11M |
| Earnings Per Share (EPS) | $1.17 |
Full Income StatementBalance Sheet
The company has $2.70 million in cash and $4.74 million in debt, giving a net cash position of -$2.04 million or -$0.42 per share.
| Cash & Cash Equivalents | 2.70M |
| Total Debt | 4.74M |
| Net Cash | -2.04M |
| Net Cash Per Share | -$0.42 |
| Equity (Book Value) | 8.79M |
| Book Value Per Share | 4.31 |
| Working Capital | 2.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.37 million and capital expenditures -$106,192, giving a free cash flow of -$13.48 million.
| Operating Cash Flow | -13.37M |
| Capital Expenditures | -106,192 |
| Free Cash Flow | -13.48M |
| FCF Per Share | -$2.78 |
Full Cash Flow StatementMargins
Gross margin is 31.51%, with operating and profit margins of -86.30% and 12.52%.
| Gross Margin | 31.51% |
| Operating Margin | -86.30% |
| Pretax Margin | 2.62% |
| Profit Margin | 12.52% |
| EBITDA Margin | -85.95% |
| EBIT Margin | -86.30% |
| FCF Margin | n/a |
Dividends & Yields
NewGenIvf Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 40.79% |
| FCF Yield | -920.86% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 167.43% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 4, 2025. It was a reverse split with a ratio of 1:5.
| Last Split Date | Aug 4, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
NewGenIvf Group has an Altman Z-Score of 0.13 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.13 |
| Piotroski F-Score | 3 |
